Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Coherus BioSciences Inc (NASDAQ:CHRS)

26.29
Delayed Data
As of 3:59pm ET
 -2.50 / -8.68%
Today’s Change
12.04
Today|||52-Week Range
31.98
+14.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues1.9M2.8M31.1M30.0M
 
 
 
 
 
Depreciation And Amortization221.0K404.0K674.0K1.9M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses40.2M38.3M95.0M246.9M
 
 
 
 
 
Research And Development34.9M31.3M78.2M212.7M
 
 
 
 
 
Total Operating Expenses40.4M38.7M95.7M248.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-38.5M-36.0M-64.5M-218.7M
 
 
 
 
 
Extraordinary Credit----2.0M--
 
 
Extraordinary Charge-----21.2M-5.0M
 
 
 
Interest Expense On Debt1.5M5.3M3.8M33.0K
 
 
 
 
 
Other Expenses7.0M-12.3M377.0K-239.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-33.0M-53.6M-87.2M-223.9M
 
 
 
 
 
Minority Interest0.000.00-44.0K-678.0K
 
 
 
Net Income-33.0M-53.6M-87.1M-223.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS38.4M38.4M8.2M37.1M
 
 
 
 
 
Shares To Calculate EPS Diluted38.4M38.4M8.2M37.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$9.51-$9.66-$10.64-$6.01
 
 
 
 
 
EPS Diluted-$0.86-$1.40-$10.64-$6.01